Eosinophilia
17 results
1 - 17
No evidence that dupilumab is effective as add-on therapy in mod-severe asthma with eosinophilia- In high-risk patients with chronic obstructive pulmonary disease, dupilumab slightly reduces moderate exacerbation (BOREAS)
- Mepolizumab provides a small reduction in the exacerbations of moderate to severe eosinophilic COPD
- One year of once-daily doxycycline does not reduce exacerbation frequency in adults with moderate to severe COPD
- The American Thoracic Society guideline for managing patients with chronic obstructive pulmonary disease
- Some support for the hygiene hypothesis: less asthma in nonmechanized farming environment
- Azithromycin reduces frequency of exacerbations in adults with persistent asthma